Manifold Bio

Director, Client Solutions

Newton, Massachusetts, United States

Manifold Bio Logo
Not SpecifiedCompensation
Junior (1 to 2 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Health Research, Clinical Research, Biotechnology, Healthcare TechnologyIndustries

Requirements

Candidates should possess 7+ years of experience in a customer-facing role, with at least 2+ years of experience in a technical pre-sales sales role selling to large enterprises. They should demonstrate a strong desire to leverage consultative selling skills and develop in-depth knowledge of the company’s technology and market, particularly within the rapidly evolving field of AI. Furthermore, candidates must be able to interact with a wide range of stakeholders, including C-level executives and end users, utilizing a consultative selling approach.

Responsibilities

The Director, Client Solutions will solve problems for potential customers by understanding their situation and challenges, showcasing the value of Manifold’s AI-powered clinical research platform, and crafting solutions using the product suite. They will build trusted, consultative relationships with stakeholders, deliver captivating product demos, collaborate with Sales and Marketing teams, provide insights and learnings, drive adoption during proof of value, translate use cases into technical solutions, and provide feedback to product management. Additionally, they will assist in post-sales implementation activities as needed.

Skills

Customer-facing
Pre-sales
Consultative Selling
Technical Demonstrations
Stakeholder Engagement
Solution Selling
Product Demos
ROI Analysis
Customer Relationship Management

Manifold Bio

Designs precision biologics using in vivo methods

About Manifold Bio

Manifold Bio specializes in creating precision biologics for the pharmaceutical industry, focusing on drug design and development. Their main product is an in vivo drug design platform, which allows for testing drugs within living organisms rather than in laboratory settings. This platform utilizes mCodes™ technology, a unique protein barcoding system that enables the simultaneous study of multiple proteins in one experiment, making it particularly effective for complex biologics. Unlike other companies, Manifold Bio's approach to drug design is distinct because it integrates in vivo testing with advanced protein multiplexing capabilities. The company's goal is to expand their platform and collaborate with other pharmaceutical companies to develop new therapeutics.

Key Metrics

Boston, MassachusettsHeadquarters
2020Year Founded
$58.8MTotal Funding
SERIES_ACompany Stage
Biotechnology, HealthcareIndustries
11-50Employees

Risks

Increased competition from companies like Insamo and Infinimmune.
Rapid AI and ML advancements may outpace Manifold Bio's current technology.
Regulatory challenges in in vivo testing could delay product development timelines.

Differentiation

Manifold Bio uses proprietary mCodes™ technology for protein multiplexing in drug design.
Their in vivo drug design platform is the first of its kind globally.
The company specializes in precision biologics, focusing on complex biologics development.

Upsides

Raised $40M in Series A funding, indicating strong market interest.
Their platform could revolutionize in vivo testing by testing multiple molecules simultaneously.
Strategic partnerships with multiple investors enhance growth and development opportunities.

Land your dream remote job 3x faster with AI